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Background
• Chagas disease is a chronic, systemic condition endemic in Central and South America.
• One common manifestation of this parasitic infection, Chagas heart disease (ChD), is an underdiagnosed entity with serious clinical implications.
• Data are limited regarding the demographics and clinical aspects of this disease in the United States.
• Using the U.S. Nationwide Inpatient Sample databases 2003 through 2012 and appropriate ICD-9 codes, we identified hospitalizations in patients ≥ 18 years of age with a primary or secondary diagnosis of Chagas disease and ChD.
• Cases with missing data and other cardiomyopathies were excluded for analysis purposes.
• Demographics and various cardiac conditions were then analyzed using appropriate ICD-9 codes.
Results
• Of the 1,577 hospitalizations with a diagnosis of Chagas disease, 1050 (66.6%) had diagnosed CHD (mean age 57±15 years, 50.0% women, 74.1% Hispanic).
• The largest numbers CHD cases were seen in California (33%), followed by Florida (14%) and New York (10%).
• Congestive heart failure (CHF) (28%) was the most common primary discharge diagnosis, followed by dysrhythmias (9.4%).
• Hospitalization with a recognized diagnosis of CHD is uncommon in the US.
• Patients hospitalized with CHD are generally young and demonstrate severe cardiac disease, including a very high burden of CHF and arrhythmias from underlying chronic myocarditis.
• The rates of device implantation are high in CHD population.
• CHD is associated with substantial hospitalization costs.
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• In patients with CHD, CHF was present in 63%, arrhythmias in 58.5%, conduction abnormalities in 12.2%, and cardiac devices in 41.2% (Figure) .
• Median length of stay was 5 days, median hospitalization charges were US$ 33,591, and all-cause inpatient mortality was 3.3%. 28.7%
